Sector News

Sweden’s Sobi says terminates takeover talks

June 9, 2015
Chemical Value Chain
Swedish rare diseases drugmaker Swedish Orphan Biovitrum (Sobi) said on Monday it had terminated discussions regarding a non-binding proposal in relation to a possible offer for the company.
 
The firm said in late April it had received a preliminary proposal for a bid on the company, and Reuters identified Pfizer as the bidder.
 
“The Board of Directors of Sobi has terminated discussions regarding this proposal,” Sobi said in a statement.
 
“Sobi will continue to focus on preparations for the upcoming planned launch of Elocta and Alprolix and on building value through its diverse and growing portfolio.”
 
(Reporting by Johannes Hellstrom; editing by Niklas Pollard)

comments closed

Related News

February 4, 2023

Eastman acquires performance films company Ai-Red Technology

Chemical Value Chain

Eastman Chemical Co. (Kingsport, Tenn.) announced it has acquired Ai-Red Technology (Dalian) Co., Ltd., a manufacturer and supplier of paint protection and window film for auto and architectural markets in the Asia Pacific region.

February 4, 2023

BASF and StePac partner on chemical recycling MAP packs to fight food waste

Chemical Value Chain

BASF and Israeli packager StePac have joined forces to create the “next generation” of fresh produce packaging. BASF will provide StePac with greater flexibility to advance contact-sensitive packaging formats to a higher sustainability standard by supplying StePac with Ultramid Ccycled – a chemically recycled polyamide 6.

February 4, 2023

TotalEnergies and Intraplás partner on food-grade renewable biopolymer production

Chemical Value Chain

TotalEnergies’ biorefinery in La Mède, France, allows direct access to renewable feedstock for its drop-in RE:newable polymer range derived from bio-based products. The company claims these polymers retain virgin-like properties.

How can we help you?

We're easy to reach